Abstract CT004: Adjuvant therapy with nivolumab (NIVO) combined with ipilimumab (IPI) vs NIVO alone in patients (pts) with resected stage IIIB-D/IV melanoma (CheckMate 915)Georgina V. Long, Jeffrey S. Weber, Michele Del Vecchio et al.|Cancer Research|2021Cited by 36